Surabhi Dayal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Surabhi Dayal has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Priyadarshini Sahu
Department of Dermatology Venereology and Leprology, Pt. B. D. Sharma University of Health Sciences Rohtak India
11 shared publications- Priyadarshini Sahu
Department of Telemedicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India
4 shared publications - Lovleen Kaur
Department of Dermatology, Venereology and Leprology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
3 shared publications Vijay Kumar Jain
Department of Dermatology, Venereology and Leprology, Pt. B. D. Sharma, Post Graduate Institute of Medical Sciences, Rohtak - Haryana, India
3 shared publicationsAshish Amrani
Senior Resident, Department of Dermatology, Venereology and Leprology, Pt B D Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
2 shared publications- Disha Chakraborty
Department of Dermatology, Mayo Clinic, Rochester, USA
2 shared publications
Latest Publications
- Open Access
- 15 March 2026
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Current Pharmaceutical Research
- p. 87-91
TREATMENT OPTIMIZATION IN RECURRENT DERMATOPHYTOSIS: A PROSPECTIVE, RANDOMIZED, COMPARATIVE STUDY OF EXTENDED-DURATION VERSUS HIGH-DOSE TERBINAFINE AND ITRACONAZOLE
Objective: To compare efficacy and safety of terbinafine versus itraconazole administered in double dose and prolonged duration in patients with recurrent tinea corporis and cruris. Methods: This prospective, randomized study included 166 patients in four groups: A (terbinafine 250 mg once daily (OD), 4 w), B (terbinafine 500 mg OD, 2 w), C (itraconazole 100 mg twice daily (BD), 4 w), and D (itraconazole 200 mg BD, 2 w). Primary outcomes were clinical/mycological cure, global assessment, safety; secondary outcomes included quality of life, escape treatment, adherence. Significance was set at p<0.05. Results: Group C had highest efficacy (92.7% clinical cure and 100% mycological cure) with lowest recurrence. Liver Function Tests (LFTs) showed no significant abnormalities across all groups. No therapy discontinuations/serious Adverse Drug Reactions (ADRs) were reported. Dermatology Life Quality Index (DLQI) improved significantly from baseline to treatment end and 6 w post-treatment, indicating substantial and sustained improvement. Treatment compliance was high across all groups (≥90%), with no significant difference. Conclusion: Itraconazole 100 mg BD for 4 w was most effective, well-tolerated regimen, highlighting benefit of extended duration over increased dose in recurrent dermatophytosis.
- 15 March 2026
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Current Pharmaceutical Research
- p. 87-91
Open AccessTREATMENT OPTIMIZATION IN RECURRENT DERMATOPHYTOSIS: A PROSPECTIVE, RANDOMIZED, COMPARATIVE STUDY OF EXTENDED-DURATION VERSUS HIGH-DOSE TERBINAFINE AND ITRACONAZOLE
Objective: To compare efficacy and safety of terbinafine versus itraconazole administered in double dose and prolonged duration in patients with recurrent tinea corporis and cruris. Methods: This prospective, randomized study included 166 patients in four groups: A (terbinafine 250 mg once daily (OD), 4 w), B (terbinafine 500 mg OD, 2 w), C (itraconazole 100 mg twice daily (BD), 4 w), and D (itraconazole 200 mg BD, 2 w). Primary outcomes were clinical/mycological cure, global assessment, safety; secondary outcomes included quality of life, escape treatment, adherence. Significance was set at p<0.05. Results: Group C had highest efficacy (92.7% clinical cure and 100% mycological cure) with lowest recurrence. Liver Function Tests (LFTs) showed no significant abnormalities across all groups. No therapy discontinuations/serious Adverse Drug Reactions (ADRs) were reported. Dermatology Life Quality Index (DLQI) improved significantly from baseline to treatment end and 6 w post-treatment, indicating substantial and sustained improvement. Treatment compliance was high across all groups (≥90%), with no significant difference. Conclusion: Itraconazole 100 mg BD for 4 w was most effective, well-tolerated regimen, highlighting benefit of extended duration over increased dose in recurrent dermatophytosis.
- Open Access
- 22 August 2025
- Published by Medip Academy in International Journal of Basic & Clinical Pharmacology
- Vol. 14 (5) , 781-785
Analyzing gaps in knowledge, attitude, and behavioral practices related to seborrhoeic dermatitis among medical undergraduate students
Background: Seborrhoeic dermatitis (SD) is a prevalent, chronic, inflammatory skin condition, primarily affecting areas rich in sebaceous glands, yet awareness of its etiology, management, and associated psychosocial impact remains limited. This study aimed to assess the knowledge, attitudes, and practices (KAP) regarding seborrhoeic dermatitis among undergraduate medical students. Methods: A cross-sectional observational study was conducted from January to March 2024 at Pt. B. D. Sharma PGIMS, Rohtak, involving 379 medical undergraduates (aged 18–30). Data were collected via a structured, self-administered, expert-validated questionnaire covering general information, knowledge, attitudes, and practices regarding SD. Institutional Ethics Committee approval was obtained. Data were analyzed in Excel using descriptive statistics (mean±SD for continuous and percentages for categorical variables). Results: Among participants, 69.9% had experienced SD, with 48.5% currently affected. Knowledge gaps were evident: only 21.4% identified SD as a chronic inflammatory condition, and 28.5% recognized Malassezia as the cause. While fungal involvement was widely acknowledged, specific understanding was limited. Only 10.9% were satisfied with current treatments, and 48.2% believed oiling was beneficial, despite contrary evidence. Practices such as towel sharing (18.6%) and frequent scalp scratching (63.8%) were common, potentially worsening the condition. Conclusions: The study identified significant gaps in knowledge, attitudes, and practices regarding SD among medical undergraduates. Educational interventions targeting these gaps are necessary to improve awareness, debunk myths, and promote evidence-based management strategies for SD.
- 22 August 2025
- Published by Medip Academy in International Journal of Basic & Clinical Pharmacology
- Vol. 14 (5) , 781-785
Open AccessAnalyzing gaps in knowledge, attitude, and behavioral practices related to seborrhoeic dermatitis among medical undergraduate students
Background: Seborrhoeic dermatitis (SD) is a prevalent, chronic, inflammatory skin condition, primarily affecting areas rich in sebaceous glands, yet awareness of its etiology, management, and associated psychosocial impact remains limited. This study aimed to assess the knowledge, attitudes, and practices (KAP) regarding seborrhoeic dermatitis among undergraduate medical students. Methods: A cross-sectional observational study was conducted from January to March 2024 at Pt. B. D. Sharma PGIMS, Rohtak, involving 379 medical undergraduates (aged 18–30). Data were collected via a structured, self-administered, expert-validated questionnaire covering general information, knowledge, attitudes, and practices regarding SD. Institutional Ethics Committee approval was obtained. Data were analyzed in Excel using descriptive statistics (mean±SD for continuous and percentages for categorical variables). Results: Among participants, 69.9% had experienced SD, with 48.5% currently affected. Knowledge gaps were evident: only 21.4% identified SD as a chronic inflammatory condition, and 28.5% recognized Malassezia as the cause. While fungal involvement was widely acknowledged, specific understanding was limited. Only 10.9% were satisfied with current treatments, and 48.2% believed oiling was beneficial, despite contrary evidence. Practices such as towel sharing (18.6%) and frequent scalp scratching (63.8%) were common, potentially worsening the condition. Conclusions: The study identified significant gaps in knowledge, attitudes, and practices regarding SD among medical undergraduates. Educational interventions targeting these gaps are necessary to improve awareness, debunk myths, and promote evidence-based management strategies for SD.
- 19 August 2024
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 151 (3) , 103285
Comedo-like Lesions on a verrucous epidermal nevus
- 19 August 2024
- Published by Elsevier in Annales de Dermatologie et de Vénéréologie
- Vol. 151 (3) , 103285
Comedo-like Lesions on a verrucous epidermal nevus
- Open Access
- 31 October 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (4) , e2023217
Lichenoid Pseudovesicular Papular Eruption on the Nose With Dermoscopic Features: A Case Series
Citation: Gupta I, Kaur L, Bansal A, Dayal S, Kumar S. Lichenoid Pseudovesicular Papular Eruption on the Nose With Dermoscopic Features: A Case Series. Dermatol Pract Concept. 2023;13(4):e2023217. DOI: https://doi.org/10.5826/dpc.1304a217 Accepted: April 3, 2023; Published: October 2023 Copyright: ©2023 Gupta et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Aanchal Bansal, MBBS, Junior Resident, Department of Dermatology, Venereology and Leprology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India. Tel: +917086878303; Email: aanchal.bansal.ab125@gmail.com Keywords : LIPEN, lichenoid, dermoscopy, facial papules, pseudovesicles This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- 31 October 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (4) , e2023217
Open AccessLichenoid Pseudovesicular Papular Eruption on the Nose With Dermoscopic Features: A Case Series
Citation: Gupta I, Kaur L, Bansal A, Dayal S, Kumar S. Lichenoid Pseudovesicular Papular Eruption on the Nose With Dermoscopic Features: A Case Series. Dermatol Pract Concept. 2023;13(4):e2023217. DOI: https://doi.org/10.5826/dpc.1304a217 Accepted: April 3, 2023; Published: October 2023 Copyright: ©2023 Gupta et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Aanchal Bansal, MBBS, Junior Resident, Department of Dermatology, Venereology and Leprology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India. Tel: +917086878303; Email: aanchal.bansal.ab125@gmail.com Keywords : LIPEN, lichenoid, dermoscopy, facial papules, pseudovesicles This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- 9 May 2023
- Published by Wiley in Pediatric Dermatology
- Vol. 40 (6) , 1112-1114
Addisonian pigmentation associated with acute lymphoblastic leukemia: A rare paraneoplastic phenomenon
Addisonian pigmentation usually presents with nonspecific symptoms and signs, which are often ignored or misdiagnosed as a sign of other more common diseases. We present a case of 12-year-old child in whom diffuse Addisonian hyperpigmentation of skin was associated with underlying acute lymphoblastic leukemia (B-type), a rare paraneoplastic phenomenon in hematological malignancies.
- 9 May 2023
- Published by Wiley in Pediatric Dermatology
- Vol. 40 (6) , 1112-1114
Addisonian pigmentation associated with acute lymphoblastic leukemia: A rare paraneoplastic phenomenon
Addisonian pigmentation usually presents with nonspecific symptoms and signs, which are often ignored or misdiagnosed as a sign of other more common diseases. We present a case of 12-year-old child in whom diffuse Addisonian hyperpigmentation of skin was associated with underlying acute lymphoblastic leukemia (B-type), a rare paraneoplastic phenomenon in hematological malignancies.
- 1 February 2023
- Published by Wiley in Pediatric Dermatology
- Vol. 40 (4) , 669-672
Disseminated cysticercosis with multi‐system involvement in a child
We report a rare case of disseminated cysticercosis in a 7-year-old Indian girl with recent onset seizures treated with antiepileptics for 2 months. When she presented to dermatology clinic, she had multifocal subcutaneous and submucosal nodules. The subsequent diagnostic workup revealed extensive neurocysticercosis as well as orbital and myocysticercosis.
- 1 February 2023
- Published by Wiley in Pediatric Dermatology
- Vol. 40 (4) , 669-672
Disseminated cysticercosis with multi‐system involvement in a child
We report a rare case of disseminated cysticercosis in a 7-year-old Indian girl with recent onset seizures treated with antiepileptics for 2 months. When she presented to dermatology clinic, she had multifocal subcutaneous and submucosal nodules. The subsequent diagnostic workup revealed extensive neurocysticercosis as well as orbital and myocysticercosis.
- Open Access
- 31 January 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (1) , e2023028
Various Color Presentations of Pseudochromhidrosis—A Case Series
Citation: Sahu P, Chakraborty D, Dayal S, Sachdeva M. Various Colors of Presentation of Pseudochromhidrosis - A Case Series. Dermatol Pract Concept. 2023;13(1):e2023028. DOI: https://doi.org/10.5826/dpc.1301a28 Accepted: June 8, 2022; Published: January 2023 Copyright: ©2023 Sahu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Priyadarshini Sahu, Department of Dermatology, Venereology and Leprosy, Pt. B. D. Sharma, University of Health Sciences, Rohtak, 1075, First floor, Adarsh Nagar, Rohtak, Haryana, India. Pin-124001 Tel: +91-9416536159 E-mail: priyadarshini.sahu.9@gmail.com Keywords : Pseudochromhidrosis, red, black, pink This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- 31 January 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (1) , e2023028
Open AccessVarious Color Presentations of Pseudochromhidrosis—A Case Series
Citation: Sahu P, Chakraborty D, Dayal S, Sachdeva M. Various Colors of Presentation of Pseudochromhidrosis - A Case Series. Dermatol Pract Concept. 2023;13(1):e2023028. DOI: https://doi.org/10.5826/dpc.1301a28 Accepted: June 8, 2022; Published: January 2023 Copyright: ©2023 Sahu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Priyadarshini Sahu, Department of Dermatology, Venereology and Leprosy, Pt. B. D. Sharma, University of Health Sciences, Rohtak, 1075, First floor, Adarsh Nagar, Rohtak, Haryana, India. Pin-124001 Tel: +91-9416536159 E-mail: priyadarshini.sahu.9@gmail.com Keywords : Pseudochromhidrosis, red, black, pink This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- Open Access
- 1 October 2022
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 12 (4) , e2022156
Subcutaneous Granuloma Annulare in an Atypical Age Group in Immediate Post-COVID Phase
Citation: Kaur L, Chakraborty D, Dayal S, Singh S, Yadav K. Subcutaneous Granuloma Annulare in an atypical age group in immediate post-covid phase. Dermatol Pract Concept. 2022;12(4):e2022156. DOI: https://doi.org/10.5826/dpc.1204a156 Accepted: January 7, 2022; Published: October 2022 Copyright: ©2022 Kaur et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Lovleen Kaur, MD, Senior Resident, Department of Dermatology, Venereology and Leprology, Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India. Tel: +917888661584; Email: dr.lovleen555@gmail.com Keywords : Granuloma Annulare, Covid-19, SARS-Cov-2, Palisading granuloma, Subcutaneous GA This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- 1 October 2022
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 12 (4) , e2022156
Open AccessSubcutaneous Granuloma Annulare in an Atypical Age Group in Immediate Post-COVID Phase
Citation: Kaur L, Chakraborty D, Dayal S, Singh S, Yadav K. Subcutaneous Granuloma Annulare in an atypical age group in immediate post-covid phase. Dermatol Pract Concept. 2022;12(4):e2022156. DOI: https://doi.org/10.5826/dpc.1204a156 Accepted: January 7, 2022; Published: October 2022 Copyright: ©2022 Kaur et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Lovleen Kaur, MD, Senior Resident, Department of Dermatology, Venereology and Leprology, Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India. Tel: +917888661584; Email: dr.lovleen555@gmail.com Keywords : Granuloma Annulare, Covid-19, SARS-Cov-2, Palisading granuloma, Subcutaneous GA This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- 23 August 2022
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 48 (11) , 1203-1209
Efficacy of Microneedling With 35% Glycolic Acid Peels Versus Microneedling With 15% Trichloroacetic Acid Peels in Treatment of Atrophic Acne Scars: A Randomized Controlled Trial
BACKGROUND: Combination of microneedling and chemical peeling is a simple cost-effective treatment for acne scars. OBJECTIVE: To compare efficacy and safety of combining microneedling with 35% glycolic acid (GA) peel versus microneedling with 15% trichloroacetic acid (TCA) peel in facial atrophic acne scars. METHODS: Forty acne scars patients were randomly divided into 2 groups of 20 each. Patients underwent microneedling followed by 35% GA peeling in Group 1 and 15% TCA peeling in Group 2 at 2 weekly intervals. Improvement was graded by Goodman and Baron's qualitative and quantitative global acne scar grading systems, physician's global assessment, and visual analogue scale (VAS). Skin texture was graded by VAS. RESULTS: On comparing qualitative and quantitative acne scar grading within groups, there was significant difference from the baseline. When the two groups were compared for quantitative and qualitative acne scar grading, the difference was statistically not significant at the end of therapy. In VAS, greater number of patients assessed response as excellent and good in Group 1 than in Group 2 indicating better skin texture improvement in Group 1. CONCLUSION: Both combinations were equally efficacious in treating acne scars. Glycolic acid peel delivered additional advantage of improvement in skin texture.
- 23 August 2022
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 48 (11) , 1203-1209
Efficacy of Microneedling With 35% Glycolic Acid Peels Versus Microneedling With 15% Trichloroacetic Acid Peels in Treatment of Atrophic Acne Scars: A Randomized Controlled Trial
BACKGROUND: Combination of microneedling and chemical peeling is a simple cost-effective treatment for acne scars. OBJECTIVE: To compare efficacy and safety of combining microneedling with 35% glycolic acid (GA) peel versus microneedling with 15% trichloroacetic acid (TCA) peel in facial atrophic acne scars. METHODS: Forty acne scars patients were randomly divided into 2 groups of 20 each. Patients underwent microneedling followed by 35% GA peeling in Group 1 and 15% TCA peeling in Group 2 at 2 weekly intervals. Improvement was graded by Goodman and Baron's qualitative and quantitative global acne scar grading systems, physician's global assessment, and visual analogue scale (VAS). Skin texture was graded by VAS. RESULTS: On comparing qualitative and quantitative acne scar grading within groups, there was significant difference from the baseline. When the two groups were compared for quantitative and qualitative acne scar grading, the difference was statistically not significant at the end of therapy. In VAS, greater number of patients assessed response as excellent and good in Group 1 than in Group 2 indicating better skin texture improvement in Group 1. CONCLUSION: Both combinations were equally efficacious in treating acne scars. Glycolic acid peel delivered additional advantage of improvement in skin texture.
- 16 April 2022
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (2) , E145-E149
Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation
A 25‐year‐old male patient presented with palmoplantar keratoderma, dystrophic nails, severe plantar pain and oral leukokeratosis since birth. On genetic analysis, a heterozygous KRT6A gene missense mutation (c.1381G > A, p.Glu461Lys in exon 7) was identified by next‐generation sequencing technology, consistent with pachyonychia congenita 6a. Oral simvastatin 40 mg was started once daily, and after 16 weeks of therapy, excellent improvement was noted in palmoplantar keratoderma and plantar pain. The maximum thickness of his foot callosity reduced by 4 mm on ultrasonography, and the Dermatology Life Quality Index score dropped significantly by eight points. These benefits may be attributed to inhibition of KRT6A gene expression, modulation of autophagy and mitophagy and Keap1‐Nrf2 signalling activation; the latter two mechanisms of statins previously undiscussed in the context of pachyonychia congenita. Simvastatin and other statins are pathogenesis‐targeted, disease‐modifying therapy in pachyonychia congenita, therefore qualifying as a promising treatment avenue and warranting further clinical trials.
- 16 April 2022
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (2) , E145-E149
Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation
A 25‐year‐old male patient presented with palmoplantar keratoderma, dystrophic nails, severe plantar pain and oral leukokeratosis since birth. On genetic analysis, a heterozygous KRT6A gene missense mutation (c.1381G > A, p.Glu461Lys in exon 7) was identified by next‐generation sequencing technology, consistent with pachyonychia congenita 6a. Oral simvastatin 40 mg was started once daily, and after 16 weeks of therapy, excellent improvement was noted in palmoplantar keratoderma and plantar pain. The maximum thickness of his foot callosity reduced by 4 mm on ultrasonography, and the Dermatology Life Quality Index score dropped significantly by eight points. These benefits may be attributed to inhibition of KRT6A gene expression, modulation of autophagy and mitophagy and Keap1‐Nrf2 signalling activation; the latter two mechanisms of statins previously undiscussed in the context of pachyonychia congenita. Simvastatin and other statins are pathogenesis‐targeted, disease‐modifying therapy in pachyonychia congenita, therefore qualifying as a promising treatment avenue and warranting further clinical trials.